Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Genixine
- Development stage
- Unknown
- Lead developer
- Ceva Santé Animale
- Modality
- Small Molecules
- Administration
- Intramuscular, Intravenous
01
Overview
Genixine is a veterinary injectable formulation of the non-steroidal anti-inflammatory drug flunixin meglumine, used primarily in cattle, pigs, and horses to reduce pain, inflammation, and fever associated with respiratory disease and periparturient or reproductive disorders. As an NSAID, flunixin inhibits cyclooxygenase enzymes (COX), leading to decreased synthesis of prostaglandins that mediate inflammation, nociception, and pyrexia, thereby improving animal welfare and supporting recovery and productivity in livestock.[7][9][13][14]
- Brand names
- GenixineGenixine R
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Genixine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genixine.